2000

  1. 5ASA in CD for postoperative recurrence

  2. 5ASA suppositories maintenance in UC proctitis

  3. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn’s disease

  4. Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn’s disease

  5. Mercaptopurine in pediatric CD

  6. Mercaptopurine, methotrexate or mesalazine in IBD

  7. Early determinants of IBD use of two national longitudinal birth cohorts (Nested case-controls. UK)

  8. Smoking and CD risk (case-control. Italy)